Octave Bioscience Accelerates Precision Neurology Momentum, Appoints Zachary Fernandes as VP of Business Development to Scale Strategic Partnerships
Octave Bioscience, Inc., a commercial stage precision medicine company pioneering biomarker-driven solutions for multiple sclerosis, Parkinson's and other neurodegenerative diseases, today announced the appointment of Zachary Fernandes as Vice President, Business Development. He will lead Octave’s partnership strategy focused on driving durable revenue growth through transformative, strategic collaborations across the life sciences ecosystem.






